MHRA publishes case study on Actionable Horizon Scanning Signals

Article summary

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a case study on Actionable Horizon Scanning Signals (AHSS). Identifying AHSS is part of horizon scanning in the MHRA Innovation Accelerator, in which ‘signals’ are identified from systematic searches of publicly available sources or submitted from MHRA colleagues or stakeholders outside the agency. The MHRA defines an AHSS as a signal that results in the MHRA identifying a need to change what it does, how it does it, who is involved or expanding what it knows. The effect of an AHSS being identified is the potential new development or update of guiding principles, guidelines or guidance documents, legislative changes, the establishment of new research or standardisation projects or the formation of internal interest groups or workshops and training being planned on particular topics.